AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 18, 2004). doi:10.1152/ajpheart.00722.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/3/H1425    most recent
00722.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labarthe, F.
Right arrow Articles by Des Rosiers, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labarthe, F.
Right arrow Articles by Des Rosiers, C.
Submitted on July 20, 2004
Accepted on November 11, 2004

Fatty acid oxidation and its impact on the response of spontaneously hypertensive rat hearts to an adrenergic stress: the benefit of a medium-chain fatty acid

Francois Labarthe1, Maya Khairallah2, Bertrand Bouchard1, William C. Stanley3, and Christine Des Rosiers4*

1 Department of Nutrition, University of Montreal, Montreal, Quebec, Canada
2 Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada
3 Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio, USA
4 Department of Nutrition, University of Montreal, Montreal, Quebec, Canada; Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada

* To whom correspondence should be addressed. E-mail: christine.des.rosiers{at}umontreal.ca.

The spontaneously hypertensive rat (SHR) is a model of cardiomyopathy characterized by a restricted utilization of exogenous long-chain fatty acid (LCFA) for energy production. The aims of the present study were to document the functional and metabolic response of the SHR heart under conditions of increased energy demand and the effects of a medium-chain fatty acid (MCFA, octanoate) supplementation in this situation. Hearts were perfused ex vivo in a working mode with physiological concentrations of substrates and hormones, and subjected to an adrenergic stimulation (epinephrine 10 µM). 13C-labeled substrates were used to assess substrate selection for energy production. Compared to control Wistar rat hearts, SHR hearts showed an impaired response to the adrenergic stimulation as reflected by (i) a smaller increase in contractility and developed pressure, (ii)a faster decline in the aortic flow, and (iii) greater cardiac tissue damage (lactate dehydrogenase release: 1,577 ± 118 vs 825 ± 44 mU.min-1, p<0.01). At the metabolic level, SHR hearts presented: (i) a reduced exogenous LCFA contribution to the citric acid cycle flux (16 ± 1 vs 44 ± 4 %, p<0.001) and an enhanced contribution of endogenous substrates (20 ± 4 vs 1 ± 4 %, p<0.01), and (ii) an increased lactate production from glycolysis, with a greater lactate to pyruvate production ratio. The addition of 0.2 mM octanoate reduced lactate dehydrogenase release (1,145 ± 155 vs 1,890 ± 89 mU.min-1, p<0.001) and increased exogenous fatty acid contribution to energy metabolism (23.7 ± 1.3 vs 15.8 ± 0.8 %, p<0.01), which was accompanied by an equivalent decrease in unlabeled endogenous substrate contribution, possibly triglycerides (11.6 ± 1.5 vs 19.0 ± 1.2 %, p<0.01). Taken altogether, these results demonstrate that the SHR heart shows an impaired capacity to withstand an acute adrenergic stress, which can be improved by increasing the contribution of exogenous fatty acid oxidation to energy production by MCFA supplementation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Iemitsu, N. Shimojo, S. Maeda, Y. Irukayama-Tomobe, S. Sakai, T. Ohkubo, Y. Tanaka, and T. Miyauchi
The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H136 - H144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Gelinas, F. Labarthe, B. Bouchard, J. Mc Duff, G. Charron, M. E. Young, and C. Des Rosiers
Alterations in carbohydrate metabolism and its regulation in PPAR{alpha} null mouse hearts
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1571 - H1580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. F. Allard, H. L. Parsons, R. Saeedi, R. B. Wambolt, and R. Brownsey
AMPK and metabolic adaptation by the heart to pressure overload
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H140 - H148.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. Itoh, M. Haruna, and K. Abe
Heart/Cardiac Muscle: Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats
Exp Physiol, January 1, 2007; 92(1): 147 - 159.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.